Serological status of childbearing-aged women for Toxoplasma gondii and cytomegalovirus in northern Kosovo and Metohija

Aritonović-Pribaković, Jelena; Katanic, Natasa; Radevic, Tatjana; Tasic, Mirjana Stojanovic; Kostić, Mirjana; Stolić, B.; Radulović, Aleksandra; Minic, Verica; Bojović, Ksenija; Katanić, Radoslav

doi:10.1590/0037-8682-0313-2017

Cited by 4 publications

(3 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This study demonstrated the presence of T. gondii IgG antibodies in serum samples of 41.16% of women of childbearing age living in Arad county, a well-known endemic area of Romania. The seroprevalence was higher than that reported by other European investigators: 24.1% in Northern Kosovo and Metohija [22], 22.3% in Italy [5], 22% in Portugal [7], and 29.1% in Croatia [25]. The differences in seroprevalence of T. gondii IgG antibodies between countries can be explained by different nutritional habits, as well as sociodemographic and cultural factors [17,19].…”

Section: Discussionmentioning

confidence: 55%

See 1 more Smart Citation

Seroprevalence of Toxoplasma gondii infection among women of childbearing age in an endemic region of Romania, 2016–2018

et al. 2020

View full text Add to dashboard Cite

Toxoplasmosis is an important worldwide zoonosis caused by the protozoan parasite Toxoplasma gondii. This parasitic infection is often asymptomatic in immunocompetent people. However, if the infection occurs in pregnant women, it can have serious consequences for the foetus. In this study, we evaluated the seroprevalence of T. gondii in women of childbearing age in Arad County, Western Romania. Serum samples from 2626 women were analysed using a Siemens ADVIA Centaur XP Immunoassay System. Toxoplasma gondii IgG antibodies were demonstrated in 1081 women (41%) and prevalence tended to increase with age, from 32% in women aged 15–19 years to 62% in women aged 40–45 years. There was a higher prevalence in rural areas (46%) than in urban areas (36%). This study provides new data on T. gondii seroprevalence in women of childbearing age from Western Romania.

show abstract

Section: Discussionmentioning

confidence: 55%

“…The overall seroprevalence of T. gondii IgG antibodies in Europe, in women of childbearing age, was estimated at 23% in 2014 [6]. Seroprevalence varies in different countries: 37% in France [14], 25.9% in Germany [27], 33% in Serbia [22], and 29.1% in Croatia [25].…”

Section: Introductionmentioning

confidence: 99%

Seroprevalence of Toxoplasma gondii infection among women of childbearing age in an endemic region of Romania, 2016–2018

et al. 2020

View full text Add to dashboard Cite

show abstract

“…19 Also, the study from Kosovo among childbearing-aged women found CMV seroprevalence of 96.2%. 20 Recently, the study performed on pregnant women in Tuzla and Mostar in Bosnia and Herzegovina found high CMV seroprevalence of 93% and 92%, respectively. 21,22 In accordance to this, we could presume that CMV seroprevalence among paediatric population in Bosnia and Herzegovina would be same as in low SES and developing countries from Asia or Africa.…”

Section: Discussionmentioning

confidence: 99%

The cytomegalovirus seroprevalence among children in Mostar, Bosnia and Herzegovina: A hospital cross-sectional study

Franjić

Karlovic

Rajič

et al. 2020

Clinical Epidemiology and Global Health

View full text Add to dashboard Cite

show abstract

A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development

Fowler

Mucha²,

Neumann³

et al. 2022

BMC Public Health

View full text Add to dashboard Cite

Background Cytomegalovirus (CMV) is a common pathogen that affects individuals of all ages and establishes lifelong latency. Although CMV is typically asymptomatic in healthy individuals, infection during pregnancy or in immunocompromised individuals can cause severe disease. Currently, treatments are limited, with no prophylactic vaccine available. Knowledge of the current epidemiologic burden of CMV is necessary to understand the need for treatment and prevention. A systematic literature review (SLR) was conducted to describe the most recent epidemiologic burden of CMV globally. Methods Medline, Embase, and LILACS were searched to identify data on CMV prevalence, seroprevalence, shedding, and transmission rates. The SLR covered the time period of 2010–2020 and focused geographically on Australia, Europe, Israel, Japan, Latin America (LATAM), and North America. Studies were excluded if they were systematic or narrative reviews, abstracts, case series, letters, or correspondence. Studies with sample sizes < 100 were excluded to focus on studies with higher quality of data. Results Twenty-nine studies were included. Among adult men, CMV immunoglobulin G (IgG) seroprevalence ranged from 39.3% (France) to 48.0% (United States). Among women of reproductive age in Europe, Japan, LATAM, and North America, CMV IgG seroprevalence was 45.6-95.7%, 60.2%, 58.3-94.5%, and 24.6-81.0%, respectively. Seroprevalence increased with age and was lower in developed than developing countries, but data were limited. No studies of CMV immunoglobulin M (IgM) seroprevalence among men were identified. Among women of reproductive age, CMV IgM seroprevalence was heterogenous across Europe (1.0-4.6%), North America (2.3-4.5%), Japan (0.8%), and LATAM (0-0.7%). CMV seroprevalence correlated with race, ethnicity, socioeconomic status, and education level. CMV shedding ranged between 0% and 70.2% depending on age group. No findings on CMV transmission rates were identified. Conclusions Certain populations and regions are at a substantially higher risk of CMV infection. The extensive epidemiologic burden of CMV calls for increased efforts in the research and development of vaccines and treatments. Trial registration N/A.

show abstract

Serological status of childbearing-aged women for Toxoplasma gondii and cytomegalovirus in northern Kosovo and Metohija

Cited by 4 publications

References 12 publications

Seroprevalence of Toxoplasma gondii infection among women of childbearing age in an endemic region of Romania, 2016–2018

Seroprevalence of Toxoplasma gondii infection among women of childbearing age in an endemic region of Romania, 2016–2018

The cytomegalovirus seroprevalence among children in Mostar, Bosnia and Herzegovina: A hospital cross-sectional study

A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development

Contact Info

Product

Resources

About